跳至主要内容
临床试验/NCT03403985
NCT03403985Unknown不适用

Long-term Evaluation of Direct Pulp Capping Using Either Mineral Trioxid Aggregate or Calcium Hydroxide in Permanent Mature Teeth: A Randomized Controlled Trial

Jordan University of Science and Technology1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
clinical vital pulp therapy success

研究概览

简要总结

Calcium hydroxide and mineral trioxide aggregate have been used in vital pulp therapy with variable outcomes recorded by different study. They will be compared when used for direct pulp capping in cariously exposed mature permanent teeth.

详细描述

Vital pulp therapy has the benefit of providing patients with a conservative treatment option with relatively low cost when compared to conventional root canal treatment and spares them possible post-treatment consequences that might occur. Vital pulp treatment in trauma cases is associated with high success rate but controversy still exists regarding vital pulp treatment in carious-exposed pulp.

The purpose of this study is to evaluate the success rate of direct pulp capping performed with MTA-Angelus® or calcium hydroxide in mechanical-exposed or carious-exposed mature permanent human teeth. Patients included in this study will be recruited from routine dental patients attending conservative clinics in JUST Dental Teaching Centre. Adult patients scheduled for routine conservative treatment involving caries removal and restoration with mechanical or carious pulp exposure will be invited to participate in this study.

A total of 80 carious human teeth with carious pulp exposure will be included in this randomized clinical study. Patients are among those scheduled for conservative dental treatment and end with pulp exposure. The patients and/or their parents will be asked to sign a consent form after receiving a detailed explanation about the study rationale, clinical procedures, and possible risks. The exposed teeth will be divided randomly into two experimental groups (n=40) according to the dressing materials; MTA-Angelus® or calcium hydroxide, then teeth will be restored with permanent filling. Teeth will be reviewed recording any signs and symptoms. Patients will be reviewed in 1 week, 3 months and yearly after. MTA-Angelus and calcium hydroxide are anticipated to be biocompatible and induce hard tissue barrier. This project will reveal if tested materials are presented with promising profile upon using as direct pulp capping dressing in mechanical and carious-exposed pulp.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

patients are not aware about type of capping material used

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • carious teeth that had no previous root canal treatment
  • Pulpal diagnosis of normal or reversible pulpitis

排除标准

  • History of irreversible pulpal pain
  • Immature teeth
  • Non restorable teeth
  • Teeth with active periodontal disease
  • History of any systemic disease
  • Concurrent medication with systemic steroids, antibiotics, analgesics, immunomodulatory drugs or cytotoxics

研究组 & 干预措施

calcium hydroxide direct pulp capping

Experimental

calcium hydroxide (Ca(OH)2 direct pulp capping will be performed in this group

干预措施: Calcium Hydroxide (Ca(OH)2) (Drug)

MTA direct pulp capping

Experimental

Mineral Trioxide Aggregate (MTA) direct pulp capping will be performed in this group

干预措施: Mineral Trioxide Aggregate (Drug)

结局指标

主要结局

clinical vital pulp therapy success

时间窗: from date of randomization until failure reported for up to 100 months

Treatment was considered successful based on the absence of symptoms and signs Treatment was considered successful based on absence of symptoms and signs

次要结局

  • Radiographic success(from date of randomization until failure reported for up to 100 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验